Benchmark analyst Josh Sullivan maintains Ultralife (NASDAQ:ULBI) with a Buy and raises the price target from $13 to $14.
- Headlines
- Benchmark Maintains Buy on Ultralife, Raises Price Target to $14
Benchmark Maintains Buy on Ultralife, Raises Price Target to $14
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Write a comment
0 0 0
LikeLoveLaughing CryRespectEmmSadAngry
Tap to Select a Mood
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
Use the share button in your browser
to share the page with your friends
Tap here to share
No comments yet. Write one.
Related Stocks Related Stocks
Symbol Mini Chart Latest Price
Unlock the Full List
Latest
00:52
Turkey's Erdogan: What Turkey needs to do is support Syria's efforts to rebuild the country.
00:51
Aldo Spanjer, a commodity strategy analyst at BNP Paribas, expects the average price of Brent crude oil to be $71 per barrel in 2026.
BNPQY+3.31%
00:50
Analysts including Max Layton from citigroup predict a "significant supply surplus" of 1.5 million barrels per day in the second quarter of 2025 in the 2025 global csi commodity equity index outlook. The average price of Brent crude oil in 2025 may be $60 per barrel, and this level may continue in 2026.
C+0.35%